BOT — Botanix Pharmaceuticals Balance Sheet
0.000.00%
- AU$763.40m
- AU$715.83m
- AU$0.60m
Annual balance sheet for Botanix Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 24.6 | 21.6 | 7.29 | 10.3 | 79.3 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.131 | 0.045 | 0.141 | 0.489 | 2.28 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 24.8 | 21.6 | 10.5 | 14 | 82.9 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.445 | 0.278 | 0.179 | 0.065 | 0.072 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 25.3 | 22 | 14 | 24.8 | 112 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.38 | 1.04 | 5.89 | 1.89 | 3.73 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 1.67 | 1.15 | 5.89 | 1.89 | 3.73 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 23.6 | 20.8 | 8.15 | 23 | 109 |
Total Liabilities & Shareholders' Equity | 25.3 | 22 | 14 | 24.8 | 112 |
Total Common Shares Outstanding |